Patients with wet macular degeneration (MD) who are receiving Avastin injections will again be entitled to a Medicare Rebate.
Foundation’s campaigns leading to increase in macular degeneration awareness in Australia.
An advocacy campaign relating to the Extended Medicare Safety Net has been resolved positively for thousands of elderly Australians with wet AMD.
Many macular degeneration clients are affected by the decision not to fund OCT.
New changes to Medicare mean a $200 rebate is no longer available for the administration of Avastin as a treatment for MD.
Melbourne research has considered the link between alcohol and age-related macular degeneration.
A Macular Disease Patient Charter has been developed.
The Vision Van – a mobile eye screening van to increase detection of AMD – has been launched.
MD Foundation has added its voice to the call for improved access to Audio Descriptive in the electronic media.